Cancer stem cell immunoediting by IFNγ. Academic Article uri icon

Overview

abstract

  • The secretion of interferon gamma (IFNG, best known as IFNγ) by immune effector cells generally mediates potent anticancer effects. Recent data from Beziaud et al. demonstrate that—at least in some circumstances—IFNγ can edit the breast cancer microenvironment to promote stemness, disease progression and resistance to (immuno)therapy.

publication date

  • August 21, 2023

Research

keywords

  • Neoplasms

Identity

PubMed Central ID

  • PMC10442329

Scopus Document Identifier

  • 85168527861

Digital Object Identifier (DOI)

  • 10.1038/s41419-023-06079-2

PubMed ID

  • 37604810

Additional Document Info

volume

  • 14

issue

  • 8